195 related articles for article (PubMed ID: 25821105)
1. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals.
Murdande SB; Shah DA; Dave RH
J Pharm Sci; 2015 Jun; 104(6):2094-2102. PubMed ID: 25821105
[TBL] [Abstract][Full Text] [Related]
2. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
Dai WG; Dong LC; Song YQ
Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
[TBL] [Abstract][Full Text] [Related]
3. Solubility increases associated with crystalline drug nanoparticles: methodologies and significance.
Van Eerdenbrugh B; Vermant J; Martens JA; Froyen L; Humbeeck JV; Van den Mooter G; Augustijns P
Mol Pharm; 2010 Oct; 7(5):1858-70. PubMed ID: 20822111
[TBL] [Abstract][Full Text] [Related]
4. A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions.
Shah DA; Murdande SB; Dave RH
J Pharm Sci; 2016 Jan; 105(1):10-24. PubMed ID: 26580860
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
Vippagunta SR; Wang Z; Hornung S; Krill SL
J Pharm Sci; 2007 Feb; 96(2):294-304. PubMed ID: 17051588
[TBL] [Abstract][Full Text] [Related]
7. Carrier characteristics influence the kinetics of passive drug loading into lipid nanoemulsions.
Göke K; Bunjes H
Eur J Pharm Biopharm; 2018 May; 126():132-139. PubMed ID: 28807819
[TBL] [Abstract][Full Text] [Related]
8. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):127-35. PubMed ID: 18644441
[TBL] [Abstract][Full Text] [Related]
9. Supersaturation of poorly soluble drugs induced by mesoporous magnesium carbonate.
Zhang P; Zardán Gómez de la Torre T; Welch K; Bergström C; Strømme M
Eur J Pharm Sci; 2016 Oct; 93():468-74. PubMed ID: 27590126
[TBL] [Abstract][Full Text] [Related]
10. Development of a new method to assess nanocrystal dissolution based on light scattering.
Anhalt K; Geissler S; Harms M; Weigandt M; Fricker G
Pharm Res; 2012 Oct; 29(10):2887-901. PubMed ID: 22688901
[TBL] [Abstract][Full Text] [Related]
11. Dissolution rate of griseofulvin in bile salt solutions.
de Smidt JH; Offringa JC; Crommelin DJ
J Pharm Sci; 1991 Apr; 80(4):399-401. PubMed ID: 1865343
[TBL] [Abstract][Full Text] [Related]
12. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
Balakrishnan A; Rege BD; Amidon GL; Polli JE
J Pharm Sci; 2004 Aug; 93(8):2064-75. PubMed ID: 15236455
[TBL] [Abstract][Full Text] [Related]
13. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
Sun DD; Lee PI
Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
[TBL] [Abstract][Full Text] [Related]
14. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
Peltonen L; Hirvonen J
Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology versus other techniques in improving drug dissolution.
Kwok PC; Chan HK
Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
[TBL] [Abstract][Full Text] [Related]
16. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
[TBL] [Abstract][Full Text] [Related]
17. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth.
Lindfors L; Skantze P; Skantze U; Westergren J; Olsson U
Langmuir; 2007 Sep; 23(19):9866-74. PubMed ID: 17696457
[TBL] [Abstract][Full Text] [Related]
18. Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations.
Horkovics-Kovats S
Eur J Pharm Sci; 2016 Aug; 91():265-77. PubMed ID: 27155254
[TBL] [Abstract][Full Text] [Related]
19. Solid phospholipid nano-particles: investigations into formulation and dissolution properties of griseofulvin.
Brinkmann-Trettenes U; Bauer-Brandl A
Int J Pharm; 2014 Jun; 467(1-2):42-7. PubMed ID: 24614583
[TBL] [Abstract][Full Text] [Related]
20. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
